102

News

Novo Nordisk insulin finally approved in the US

Christian Wenande
September 26th, 2015


This article is more than 9 years old.

Danish pharmaceutical giant has high hopes for products

Over 29 million people are affected by diabetes in the US (photo: Novo Nordisk)

The Danish pharmaceutical giant Novo Nordisk has announced that the US health authority, the FDA, has approved two of its products for the treatment of diabetes on the American market.

It has taken two years for the FDA to approve the two products, Tresiba and Ryzodeg, which help treat adults suffering from Type-1 and Type-2 diabetes.

“Since 1923, Novo Nordisk has been committed to advancing insulin therapy for patients with diabetes, and we are proud to bring forward the first new basal insulin molecule to be approved by the FDA in 10 years,” said Jesper Høiland, the president of Novo Nordisk in the US.

“Novo Nordisk is excited to launch Tresiba in the United States in the first quarter of 2016.”

READ MORE: Novo Nordisk to invest billions into US factory

Huge health issue
Novo Nordisk originally applied for approval on the US market in 2013, but the FDA was not convinced by the product, so the company undertook a clinical study regarding the risk of using the product.

The company has massive expectations for the US market and expects the products, already approved in Europe and Japan, to be among the leading diabetic products there within a few short years.

Over 29 million people are affected by diabetes in the US. Type 2 diabetes accounts for 90 to 95 percent of all diabetes cases. The number of Americans with diabetes has tripled over the past 30 years.


Share

Most popular

Subscribe to our newsletter

Sign up to receive The Daily Post

















Latest Podcast

A survey carried out by Megafon for TV2 has found that 71 percent of parents have handed over children to daycare in spite of them being sick.

Moreover, 21 percent of those surveyed admitted to medicating their kids with paracetamol, such as Panodil, before sending them to school.

The FOLA parents’ organisation is shocked by the findings.

“I think it is absolutely crazy. It simply cannot be that a child goes to school sick and plays with lots of other children. Then we are faced with the fact that they will infect the whole institution,” said FOLA chair Signe Nielsen.

Pill pushers
At the Børnehuset daycare institution in Silkeborg a meeting was called where parents were implored not to bring their sick children to school.

At Børnehuset there are fears that parents prefer to pack their kids off with a pill without informing teachers.

“We occasionally have children who that they have had a pill for breakfast,” said headteacher Susanne Bødker. “You might think that it is a Panodil more than a vitamin pill, if it is a child who has just been sick, for example.”

Parents sick and tired
Parents, when confronted, often cite pressure at work as a reason for not being able to stay at home with their children.

Many declare that they simply cannot take another day off, as they are afraid of being fired.

Allan Randrup Thomsen, a professor of virology at KU, has heavily criticised the parents’ actions, describing the current situation as a “vicious circle”.

“It promotes the spread of viruses, and it adds momentum to a cycle where parents are pressured by high levels of sick-leave. If they then choose to send the children to daycare while they are still recovering, they keep the epidemic going in daycares, and this in turn puts a greater burden on the parents.”